Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (23735)	5/22/2007 9:55:41 AM
From: Biomaven	Read Replies (2) of 52153

Six of the 48 trials did not report any myocardial infarctions or deaths from cardiovascular causes and therefore were not included in the analysis Yes, I noticed that as well. And it is indeed the case that the overall percentage of MI's in both groups was the same (in fact slightly higher for the control group) as claimed in IJ's post. Isn't statistics wonderful? That said, I think there is at least a whiff of smoke here, if not the raging forest fire suggested by the media coverage. ABC News last night was suggesting that this was a major drug disaster that yet again called into question the FDA's competency. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next